AVO.L Share News (AVO)
AVO Share
AVO Share
AVO Share
AVO Share
AVO
AVO Share
AVO Broker
AVO Directors
AVO Financial
AVO
AVO Short
AVOFri, 30th Dec 2022 14:33
Advanced Oncotherapy PLC - London-based particle therapy for cancer treatment - Non-Executive Director Michael Bradfield buys 500,000 shares at 13.17 pence, worth GBP65,825, on Thursday. Now has 8.4 million shares, a 1.6% stake.
Current stock price: 13.84p, closed up 4.5% on Friday in London
12-month change: down 63%
By Tom Waite, Alliance News editor
Comments and questions to newsroom@alliancenews.com
Copyright 2022 Alliance News Ltd. All Rights Reserved.
Shares in Advanced Oncotherapy (AVO) jumped 55% after it announced Sinophi Healthcare will buy its LIGHT proton therapy system for $40m to be used in a hospital in China. AVO said the purchase of the Linac Image Guided Hadron Technology (LIGHT), a particle therapy systems machine, follows a number o
Read more